Modafinil has wakefulness-promoting effects similar to those of traditional psychostimulants like amphetamine and methylphenidate, but it has lower risk for abuse and addiction. It can increase heart rate and blood pressure, but it’s not considered to be dangerous for most people.

Buy Modafinil Australia increases alertness and enhances cognition in narcoleptic patients, but it can also help those under high levels of stress (such as cancer patients or soldiers in the battle field). It can also mitigate combat fatigue caused by sleep deprivation and sleep disorders.

Increased Energy

Taking modafinil can help you stay alert, especially when you need to be. It is an FDA approved drug to treat narcolepsy, but it has also been used off label to help people with multiple sclerosis, Parkinson’s disease, and shift work sleep disorder stay awake. It can even help prevent obstructive sleep apnea/hypopnea syndrome in some patients.

This medication comes as a tablet to take by mouth. It should be taken once a day at the same time each day, with or without food. It’s best to take it in the morning if you have narcolepsy, or before your work shift starts if you have shift work sleep disorder.

It is less likely to be misused than other drugs because it doesn’t affect the brain in the same way as other stimulants and it can’t be injected or snorted. However, long-term use can lead to tolerance and dependency. It may also cause withdrawal symptoms when you stop taking it.

Increased Attention

Modafinil has been shown to improve performance on a variety of cognitive tasks in healthy people. For example, one study found that a single dose of 100 mg modafinil improved digit span and a delayed matching task. It also improved spatial planning and SSRT. However, it did not affect a number of other tests that require attention and response inhibition.

In other studies, modafinil has increased the ability to switch between stimulus representations on a visual discrimination learning task. This suggests that it increases the adoption of context-dependent strategies, which requires prefrontal cortex functioning. It has also been shown to improve performance on a task that involves attentional set-shifting and is dependent upon fronto-cortical loops, and to reduce errors made on a version of the Hayling Sentence Completion Test.

These results suggest that Modalert 200 mg increases the effectiveness of prefrontal cortical functions in a wide range of cognitive tasks. This explains why it has been found to improve performance in a variety of clinical samples and psychiatric disorders, including ADHD and major depressive disorder, although null results have been reported in schizophrenia.

Increased Memory

In addition to its alerting effects, modafinil has also been shown to improve cognition. One study using fMRI found that 3-week modafinil 400 mg/day remediated the decrement in power of the a-2 and b-1-3 bands of the EEG recorded during vigilance testing in placebo-treated patients with narcolepsy (Saletu et al, 2004).

Modafinil has also been shown to enhance working memory performance in mice on a delayed nonmatch to position task, and to increase prefrontal activity in an experiment involving the Stroop interference test in humans.

These findings have led many students, shift-workers and professionals in high-stress jobs to take advantage of the benefits of modafinil as a cognitive enhancer without having to suffer from the side effects of more traditional stimulants such as amphetamines or methylphenidate (Kim, 2012).

However, it is important to note that modafinil should only be taken under the supervision of a qualified medical practitioner. It is a schedule 4 prescription drug and should only be purchased with a prescription.

Increased Mood

Modafinil has been shown to improve mood and energy in patients with narcolepsy. Modafinil is able to increase the levels of dopamine and serotonin in your brain, which boosts your mood. In addition, modafinil can also enhance your cognitive abilities.

Modafinil has been shown to improve performance on the Stroop test and the Digit Span test. In one study, a group of 22 ADHD patients who took modafinil over the course of 4-7 days saw their scores improve on these tests.

In fMRI studies, modafinil was found to affect neural circuitry involved in emotion information processing and cognition. In particular, while amphetamine increases amygdala reactivity during an emotional information-processing task, modafinil reduces this response.

In the same study, modafinil was also found to decrease anger and hostility on the Profile of Mood States (POMS) scale, indicating that it is effective at treating depression and anxiety. However, the authors of this study were unable to find any correlation between changes in serum modafinil and changes in other POMS subscales or on anxiety as measured with the HAM-A scale.